Ebru Koca

Summary

Publications

  1. ncbi Copper deficiency with increased hematogones mimicking refractory anemia with excess blasts
    Ebru Koca
    Hematology Division, Department of Internal Medicine, Hacettepe University Medical School, Ankara, Turkey
    Leuk Res 32:495-9. 2008
  2. ncbi Renin-angiotensin system expression in the K562 human erythroleukaemic cell line
    Ebru Koca
    Hacettepe University Medical School, Departments of Internal Medicine and Haematology, Ankara, Turkey
    J Renin Angiotensin Aldosterone Syst 8:145-7. 2007
  3. ncbi Angiotensin-converting enzyme expression of the lymphoma-associated macrophages in the lymph nodes of Hodgkin's disease
    Ebru Koca
    Department of Hematology, Hacettepe University Medical School, Sihhiye, Ankara, Turkey
    J Natl Med Assoc 99:1243-4, 1246-7. 2007
  4. ncbi Overexpression of the local bone marrow renin-angiotensin system in acute myeloid leukemia
    Yavuz Beyazit
    Department of Internal Medicine, Hacettepe University Medical School, Ankara, Turkey
    J Natl Med Assoc 99:57-63. 2007
  5. ncbi Soluble platelet glycoprotein V in distinct disease states of pathological thrombopoiesis
    Kadir Acar
    Department of Hematology, Selcuk University Meram Medical School, Konya, Turkey
    J Natl Med Assoc 100:86-90. 2008
  6. ncbi Unchanged global fibrinolytic capacity during the course of hematopoietic stem cell transplantation
    Salih Aksu
    Department of Hematology, Hacettepe University Medical School, Sihhiye, Ankara, Turkey
    Blood Coagul Fibrinolysis 17:47-51. 2006
  7. ncbi Unusual extramedullary recurrences and breast relapse despite hepatic GVHD after allografting in Ph+-ALL
    Ebru Koca
    Hacettepe University, Division of Hematology, Department of Internal Medicine, Ankara, Turkey
    Hematology 11:105-7. 2006
  8. ncbi Changing clinical manifestations of a T-peripheral lymphoma: from hypereosinophilic syndrome to questionable Kimura's disease resulting in parotid mass
    Yavuz Beyazit
    Department of Internal Medicine, Hacettepe University Medical School, Ankara, Turkey
    Leuk Lymphoma 47:357-60. 2006
  9. ncbi Endogenous thrombopoietin levels during the clinical management of acute myeloid leukaemia
    Can Gonen
    Department of Internal Medicine, Hacettepe University School of Medicine, Sihhiye, 06100 Ankara, Turkey
    Platelets 16:31-7. 2005

Collaborators

Detail Information

Publications9

  1. ncbi Copper deficiency with increased hematogones mimicking refractory anemia with excess blasts
    Ebru Koca
    Hematology Division, Department of Internal Medicine, Hacettepe University Medical School, Ankara, Turkey
    Leuk Res 32:495-9. 2008
    ..An evaluation to identify the cause of copper deficiency, revealed intestinal amyloidosis. Based on our experience we recommend serum copper determination in the diagnostic workup of MDS in patients with comorbidities...
  2. ncbi Renin-angiotensin system expression in the K562 human erythroleukaemic cell line
    Ebru Koca
    Hacettepe University Medical School, Departments of Internal Medicine and Haematology, Ankara, Turkey
    J Renin Angiotensin Aldosterone Syst 8:145-7. 2007
    ..Therefore, K562 human erythroleukaemia cell line may serve as an in vitro model to elucidate the role of RAS in leukaemia and to test the effects of RAS-affecting drugs on leukaemic cellular proliferation...
  3. ncbi Angiotensin-converting enzyme expression of the lymphoma-associated macrophages in the lymph nodes of Hodgkin's disease
    Ebru Koca
    Department of Hematology, Hacettepe University Medical School, Sihhiye, Ankara, Turkey
    J Natl Med Assoc 99:1243-4, 1246-7. 2007
    ..We assessed ACE expression in the neoplastic lymph node microenvironment of Hodgkin's lymphoma (HL), particularly in macrophages and in nonneoplastic lymphoid tissue...
  4. ncbi Overexpression of the local bone marrow renin-angiotensin system in acute myeloid leukemia
    Yavuz Beyazit
    Department of Internal Medicine, Hacettepe University Medical School, Ankara, Turkey
    J Natl Med Assoc 99:57-63. 2007
    ..The aim of this study is therefore to search those major RAS components simultaneously in the leukemic blast cells taken from the bone marrow of patients with acute myeloid leukemia (AML)...
  5. ncbi Soluble platelet glycoprotein V in distinct disease states of pathological thrombopoiesis
    Kadir Acar
    Department of Hematology, Selcuk University Meram Medical School, Konya, Turkey
    J Natl Med Assoc 100:86-90. 2008
    ..Therefore, glycoprotein V system may serve to activate residual platelets in thrombocytopenia regardless of its origin is either ITP or AA...
  6. ncbi Unchanged global fibrinolytic capacity during the course of hematopoietic stem cell transplantation
    Salih Aksu
    Department of Hematology, Hacettepe University Medical School, Sihhiye, Ankara, Turkey
    Blood Coagul Fibrinolysis 17:47-51. 2006
    ..Further studies in larger HSCT populations are warranted to better understand the implications of these findings...
  7. ncbi Unusual extramedullary recurrences and breast relapse despite hepatic GVHD after allografting in Ph+-ALL
    Ebru Koca
    Hacettepe University, Division of Hematology, Department of Internal Medicine, Ankara, Turkey
    Hematology 11:105-7. 2006
    ....
  8. ncbi Changing clinical manifestations of a T-peripheral lymphoma: from hypereosinophilic syndrome to questionable Kimura's disease resulting in parotid mass
    Yavuz Beyazit
    Department of Internal Medicine, Hacettepe University Medical School, Ankara, Turkey
    Leuk Lymphoma 47:357-60. 2006
    ..This unique clinical presentation pattern of the patient may represent the distinct pathobiological progression of a clonal neoplastic lymphoproliferative disorder...
  9. ncbi Endogenous thrombopoietin levels during the clinical management of acute myeloid leukaemia
    Can Gonen
    Department of Internal Medicine, Hacettepe University School of Medicine, Sihhiye, 06100 Ankara, Turkey
    Platelets 16:31-7. 2005
    ..TPO levels in distinct AML disease states may explain the unsuccessful recombinant TPO trials and could help to design better strategies for 'pharmacological stimulation of thrombopoiesis' in AML...